This company has been marked as potentially delisted and may not be actively trading. Anzu Special Acquisition Corp I (ANZU) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock ANZU vs. MLSS, APT, RBOT, SPAI, COCH, CLGN, LFWD, POAI, HSCS, and BBLGShould you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Milestone Scientific (MLSS), Alpha Pro Tech (APT), Vicarious Surgical (RBOT), Safe Pro Group Inc. Common Stock (SPAI), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), ReWalk Robotics (LFWD), Predictive Oncology (POAI), Heart Test Laboratories (HSCS), and Bone Biologics (BBLG). These companies are all part of the "surgical appliances & supplies" industry. Anzu Special Acquisition Corp I vs. Its Competitors Milestone Scientific Alpha Pro Tech Vicarious Surgical Safe Pro Group Inc. Common Stock Envoy Medical CollPlant Biotechnologies ReWalk Robotics Predictive Oncology Heart Test Laboratories Bone Biologics Milestone Scientific (NYSE:MLSS) and Anzu Special Acquisition Corp I (NASDAQ:ANZU) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment. Does the MarketBeat Community prefer MLSS or ANZU? Milestone Scientific received 2 more outperform votes than Anzu Special Acquisition Corp I when rated by MarketBeat users. CompanyUnderperformOutperformMilestone ScientificOutperform Votes22.17%Underperform Votes9097.83% Anzu Special Acquisition Corp IN/AN/A Which has stronger valuation and earnings, MLSS or ANZU? Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Milestone Scientific. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$8.61M8.02-$6.93M-$0.07-12.57Anzu Special Acquisition Corp IN/AN/A$19.23MN/AN/A Is MLSS or ANZU more profitable? Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Anzu Special Acquisition Corp I's return on equity of -17.33% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% Anzu Special Acquisition Corp I N/A -17.33%1.37% Do insiders & institutionals believe in MLSS or ANZU? 5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 27.3% of Anzu Special Acquisition Corp I shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by company insiders. Comparatively, 0.7% of Anzu Special Acquisition Corp I shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, MLSS or ANZU? Milestone Scientific has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Anzu Special Acquisition Corp I has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. Do analysts recommend MLSS or ANZU? Milestone Scientific currently has a consensus price target of $1.25, indicating a potential upside of 42.05%. Given Milestone Scientific's stronger consensus rating and higher possible upside, equities research analysts clearly believe Milestone Scientific is more favorable than Anzu Special Acquisition Corp I.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Anzu Special Acquisition Corp I 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor MLSS or ANZU? In the previous week, Milestone Scientific had 6 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 6 mentions for Milestone Scientific and 0 mentions for Anzu Special Acquisition Corp I. Anzu Special Acquisition Corp I's average media sentiment score of 0.44 beat Milestone Scientific's score of -0.04 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media. Company Overall Sentiment Milestone Scientific Neutral Anzu Special Acquisition Corp I Neutral SummaryMilestone Scientific beats Anzu Special Acquisition Corp I on 8 of the 14 factors compared between the two stocks. Get Anzu Special Acquisition Corp I News Delivered to You Automatically Sign up to receive the latest news and ratings for ANZU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANZU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANZU vs. The Competition Export to ExcelMetricAnzu Special Acquisition Corp ISurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.47M$9.17B$5.57B$8.50BDividend YieldN/A1.26%5.28%4.16%P/E RatioN/A20.5926.6319.64Price / SalesN/A44.56407.99152.17Price / Cash3.7419.6738.2534.64Price / Book-0.815.096.964.60Net Income$19.23M$284.66M$3.23B$248.06M Anzu Special Acquisition Corp I Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANZUAnzu Special Acquisition Corp IN/A$1.37-4.9%N/A-42.9%$20.47MN/A0.003MLSSMilestone Scientific2.2655 of 5 stars$0.91+0.8%$1.25+37.0%+24.9%$71.61M$8.61M-13.0330Short Interest ↑High Trading VolumeAPTAlpha Pro Tech0.9575 of 5 stars$4.56-1.5%N/A-9.5%$49.54M$58.18M12.32120RBOTVicarious Surgical1.1209 of 5 stars$7.65+0.0%$9.25+20.9%-20.6%$45.38MN/A-0.743Gap DownSPAISafe Pro Group Inc. Common StockN/A$2.77+3.7%N/AN/A$42.03M$2.05M-3.4211News CoverageCOCHEnvoy Medical2.2505 of 5 stars$1.53+9.7%$9.25+506.6%-49.1%$32.52M$212K-1.1134Positive NewsShort Interest ↑CLGNCollPlant Biotechnologies2.7184 of 5 stars$1.94-5.4%$11.50+492.8%-71.6%$22.22M$2.47M-1.2670High Trading VolumeLFWDReWalk Robotics2.5169 of 5 stars$1.21+1.7%$9.00+643.8%-75.8%$13.32M$25.41M-0.4960Short Interest ↑Gap UpPOAIPredictive Oncology1.9689 of 5 stars$0.94-1.2%$3.00+219.6%-23.8%$8.38M$1.73M-0.3130News CoverageShort Interest ↑HSCSHeart Test Laboratories2.6549 of 5 stars$3.58-0.3%$13.00+263.1%-32.8%$3.87M$14.70K-0.4510Short Interest ↑Gap DownBBLGBone Biologics1.442 of 5 stars$0.80-0.8%N/A-49.4%$2.62MN/A0.002Stock SplitShort Interest ↓Analyst RevisionGap Down Related Companies and Tools Related Companies MLSS Competitors APT Competitors RBOT Competitors SPAI Competitors COCH Competitors CLGN Competitors LFWD Competitors POAI Competitors HSCS Competitors BBLG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANZU) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anzu Special Acquisition Corp I Please log in to your account or sign up in order to add this asset to your watchlist. Share Anzu Special Acquisition Corp I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.